Results 221 to 230 of about 4,607,044 (267)

AGO Recommendations for Diagnosis and Treatment of Patients with Early and Metastatic Breast Cancer: Update 2012 [PDF]

, 2011
Harbeck, Nadia, Scharl, Anton, Thomssen, Christoph   +2 more
core   +2 more sources

Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. [PDF]

Cancers (Basel)
Yu J, Laborde JM, Park R, Shahzad M, Kim Y, Cheon J, Imanirad I, Kim RD, Biachi de Castria T, Nardella NL, Malafa M, Denbo JW, Fleming JB, Hoffe SE, Frakes JM, Sinnamon AJ, Pimiento JM, Hodul PJ, Kim DW.   +18 more
europepmc   +1 more source

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer

, 2007
Oumar Camara, Matthias Rengsberger, A Egbe, André Koch, Mieczysław Gajda, Ulrike Hammer, Cornelia Jörke, C. Rabenstein, Michael Untch, Katharina Pachmann   +9 more
openalex   +1 more source

Neoadjuvant therapy for colorectal cancer from 2015 to 2024: a visual analysis and bibliometric analysis. [PDF]

Front Oncol
Kang B, Qiao Y, Zhu J, Li J.
europepmc   +1 more source

Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer. [PDF]

BMC Cancer
Qian L, Cairong Z, Yongdong L, Quan L, Haihu Z, Xiaofeng Z, Xuan Y, Yongcheng C, Kai C, Guanming L, Jie L.   +10 more
europepmc   +1 more source

Prospective Evaluation of Contrast-enhanced Mammography for Early Prediction of Pathologic Response after Neoadjuvant Therapy. [PDF]

Radiol Imaging Cancer
Pires-Gonçalves L, Aguiar AT, Leal C, Guimarães-Santos A, Abreu M, Henrique R.   +5 more
europepmc   +1 more source

Stoma versus no stoma prior to long-course neoadjuvant therapy in rectal cancer. [PDF]

BJS Open
Sandén G, Vinnars P, Ljuslinder I, Svensson J, Rutegård M.   +4 more
europepmc   +1 more source

Total neoadjuvant therapy in early-onset rectal cancer: A multicentre prospective cohort study. [PDF]

Colorectal Dis
Bedrikovetski S, Murshed I, Fitzsimmons T, Traeger L, Price TJ, Penniment M, Selva-Nayagam S, Vather R, Sammour T.   +8 more
europepmc   +1 more source

PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND

, 2007
J Walczak, D Pawlik, R Wojcik, M Kaczor, J Lis, G Nogas   +5 more
openalex   +1 more source